X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Formoterol is a long-acting beta-2 sympathomimetic (LABA) that widens the airways within a few minutes and keeps them open for around twelve hours. In asthma it may only be used together with inhaled cortisone, because it does not treat the inflammation and, on its own, can increase the risk of severe attacks. In COPD the situation is different: there, formoterol is also an established option as the sole maintenance medicine.
See more detail.gif)
Reminders morning and evening, a count of your reliever puffs and a history for your next appointment — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Formoterol (usually as formoterol fumarate dihydrate) |
| ATC code | R03AC13 |
| Drug class | Selective, long-acting beta-2 sympathomimetic (LABA) |
| Dosage forms | Dry powder inhalers and metered-dose inhalers — as a single ingredient and in fixed combinations with inhaled cortisone (e.g. budesonide, beclometasone, fluticasone) or with long-acting anticholinergics |
| Half-life | Terminal half-life after inhalation about 17 hours according to the SmPC; airway-widening effect around 12 hours |
| Maximum daily dose | Single-ingredient product in adults: 48 µg per day according to the SmPC; for combination products, the maximum number of puffs stated there applies |
| Onset of effect | After 1 to 3 minutes |
| Prescription status | Prescription-only medicine |
| Notable feature | In asthma only together with inhaled cortisone; in COPD also possible as sole maintenance treatment; can show up in doping tests |
The airways (bronchi) are surrounded by smooth muscle. When this muscle contracts, the airway narrows — you feel shortness of breath, tightness or wheezing. These muscle cells carry beta-2 receptors. Formoterol docks onto them and makes the muscle relax: the airways widen.¹
What makes formoterol special is the combination of two properties that other drugs have only separately. It works as fast as a reliever inhaler — after one to three minutes — and as long as a maintenance medicine, around twelve hours. Salbutamol works just as quickly, but only for a few hours; salmeterol, the other classic long-acting drug, lasts a long time but is slower to start working.
And this is exactly where the trap lies: formoterol opens the airways, but it does not treat the cause. In asthma, that cause is a chronic inflammation of the airway lining. A beta-2 agonist on its own can mask this inflammation — you feel better while it keeps smouldering.
The typical side effects also follow from the way it works. Beta-2 receptors are not found only in the airways: in skeletal muscle, activating them leads to tremor and cramps, in the heart to a faster pulse, and in the metabolism to a shift of potassium into the cells and to higher blood sugar. Because formoterol is inhaled, only part of it enters the bloodstream — which is why these effects are usually mild and dose-dependent.
The figures below describe what the SmPCs state. They are not a dosing instruction — which product and how many puffs are right for you is decided by the treating practice.¹
With inhaled medicines, technique matters at least as much as the dose. How the different types of device work is shown in detail in the guide inhaling correctly. For formoterol, a few extra points apply:
Count your reliever puffs — the history shows early on when control is slipping.
Most side effects are dose-dependent and often ease after a few days to weeks, once the body has got used to the drug.¹
Rarer, but more important: low potassium (hypokalaemia), especially together with water tablets, cortisone tablets or theophylline; higher blood sugar, which is why people with diabetes should measure more often at first; prolongation of the QT interval on the ECG and heart rhythm disorders, especially with pre-existing heart disease.¹
Formoterol is the same drug in both conditions — but the rules differ fundamentally. If you do not keep them apart, it is easy to draw the wrong conclusions: "My father takes it on its own for COPD, so I can leave out the cortisone for my asthma." That is exactly what is dangerous.
In asthma, the inflammation is at the centre. Inhaled cortisone — such as budesonide — is the foundation of treatment. Long-acting beta-2 agonists on their own can mask the inflammation, and large studies have shown that without cortisone they can increase the risk of severe, sometimes fatal asthma attacks. When they are combined with cortisone, this risk is not increased according to current knowledge.²,³
In COPD the inflammation is of a different kind and usually responds only a little to cortisone. The priority is widening the airways on a lasting basis. For mild to moderate symptoms, the German National Disease Management Guideline on COPD provides for a long-acting anticholinergic (LAMA) or a long-acting beta-2 agonist such as formoterol as single treatment, and for more severe symptoms a combination of the two.⁴ One example of a LAMA is tiotropium.
In COPD, inhaled cortisone is only added in specific cases — for example with repeated flare-ups (exacerbations) and higher eosinophil counts in the blood, or if there are also asthmatic features. Without this constellation, the benefit often does not outweigh the drawbacks, especially as inhaled cortisone can increase the risk of pneumonia in COPD.⁴,⁵
| Asthma | COPD | |
|---|---|---|
| Role of formoterol | Only as an add-on to inhaled cortisone | Alone, with a LAMA or — in specific cases — with cortisone |
| Inhaled cortisone | Foundation of treatment, practically always | Only with certain features |
| Formoterol as a reliever | Only in combination with cortisone | According to the SmPC, extra puffs possible up to the daily limit |
| Typical mistake | Leaving out the cortisone because you "can't feel it doing anything" | Continuing cortisone long term without a clear indication |
And what if both come together? If COPD shows clear asthmatic features, or if asthma has also been confirmed, the asthma rule applies again: no long-acting beta-2 agonist without cortisone. This assessment is made by the treating practice on the basis of your medical history, lung function and blood values.
The most important interactions of formoterol concern the heart, the potassium balance and drugs with the opposite mode of action.¹
| Combination | Consequence | What to do |
|---|---|---|
| Beta blockers, including as eye drops — especially non-selective ones such as propranolol | The effect of formoterol is weakened or cancelled out; in asthma, risk of the airways narrowing | Avoid according to the SmPC unless there are compelling reasons; heart-selective drugs such as bisoprolol are often tolerated — the practice decides |
| Water tablets such as furosemide, cortisone tablets such as prednisolone, theophylline | Increased potassium loss | Check potassium, especially during exacerbations and in heart disease |
| Digitalis preparations | A low potassium level increases the risk of rhythm disorders | Keep an eye on potassium |
| QT-prolonging drugs, e.g. tricyclic antidepressants such as amitriptyline, some antipsychotics, erythromycin | Increased risk of heart rhythm disorders | Inform the prescribing practice, ECG if needed |
| MAO inhibitors, tricyclic antidepressants | Stronger effect on the heart and circulation | Combine only with caution |
| Other beta-2 agonists and sympathomimetics (e.g. ephedrine in cold remedies) | Side effects add up | Never two long-acting beta-2 agonists at the same time; use the reliever according to plan |
| Anticholinergics such as tiotropium | Airway widening is increased | An intended combination in COPD |
| Anaesthetic gases (halogenated anaesthetics) | Increased risk of rhythm disorders | Mention before surgery; see medications before surgery |
Beta blockers are the trickiest combination, because they often come from the cardiology or ophthalmology side: even eye drops for glaucoma can narrow the airways in asthma. Alcohol has no specific interaction with formoterol; larger amounts of caffeine can increase palpitations and tremor. Whether anything on your list clashes is shown by the brite interaction check; the basics are in the guide drug interactions.
If you have several inhalers, it is easy to lose track of which device is for what. This overview shows where formoterol fits in:
| Drug | Group | Onset / duration | Role |
|---|---|---|---|
| Salbutamol | Short-acting beta-2 agonist | Minutes / a few hours | The classic reliever inhaler |
| Formoterol | Long-acting beta-2 agonist | 1–3 minutes / around 12 hours | Maintenance treatment; combined with cortisone also as a reliever |
| Salmeterol | Long-acting beta-2 agonist | Slower / around 12 hours | Maintenance treatment only, not as a reliever |
| Tiotropium | Long-acting anticholinergic | Slower / around 24 hours | Maintenance treatment, mainly in COPD |
| Budesonide | Inhaled cortisone | Days to weeks | Controls inflammation; the foundation in asthma |
Which checks make sense: at every appointment, your inhaler technique, symptom control — such as waking at night, a dry cough at night or limitations in everyday life — and how much reliever you use. Lung function regularly. With high doses, water tablets or heart disease, your potassium level; with diabetes, blood sugar at the start; with heart disease and QT-prolonging concomitant medicines, an ECG.¹,²
Well-controlled asthma is the most important goal in pregnancy — for mother and child. On the basis of very extensive experience, Embryotox classifies formoterol as a drug of choice and considers its use in line with the asthma guidelines to be justifiable throughout pregnancy and during breastfeeding.⁶ So if you become pregnant, do not stop your inhalers, but talk to your practice; more in the guide medications during pregnancy.
According to the SmPC, particular caution is needed with an overactive thyroid, severe high blood pressure, coronary heart disease, heart rhythm disorders, severe heart failure, certain heart muscle diseases, aneurysms and an already prolonged QT interval.¹ This does not mean that formoterol is ruled out — many people with COPD in particular also have heart disease — but dose limits are strictly observed and new symptoms such as skipped heartbeats are taken seriously. In diabetes, blood sugar is checked more often at the start.
According to the SmPC, formoterol can lead to positive results in doping tests. Under the Prohibited List of the World Anti-Doping Agency (WADA), inhaled formoterol is permitted up to a set maximum daily amount — if you take part in competitions, check the current list with NADA (Germany's National Anti Doping Agency). According to the SmPC, exercise-induced asthma that regularly requires extra puffs despite treatment is a sign of inadequate asthma control. More in the guide medications and exercise.
There is no physical withdrawal syndrome. The risk lies elsewhere: in asthma, according to the guideline, treatment is only reduced after a period of stable control, and then step by step.² Which component is reduced first is decided by the practice — leaving out the cortisone and keeping only the beta-2 agonist is not an option. In COPD, leaving it out usually simply means more breathlessness and less stamina. What a planned attempt at reduction looks like is explained in the guide stopping medications.
That depends on the product and on your plan. If you have been explicitly prescribed a combination inhaler of cortisone and formoterol for as-needed use as well, yes — up to the set maximum number of puffs. A formoterol-only product, on the other hand, is not a reliever inhaler in asthma: every extra puff would widen the airways without tackling the inflammation. In COPD, according to the SmPC, extra puffs are possible up to a daily limit. Ask for your plan in writing — including which device is the right one in an emergency.
Usually not. Tremor is the most typical side effect of beta-2 agonists and often eases after a few days to weeks. Watch whether it is linked to the number of puffs — if you are also taking a lot of salbutamol, the effects add up. If a racing heart, restlessness or muscle cramps come on top, have your pulse and potassium level checked.
Feeling fine is often precisely thanks to the cortisone — the inflammation is under control, not gone. If you have asthma and leave out the cortisone while keeping only the beta-2 agonist, you will often go on feeling fine for weeks while the inflammation returns. A reduction is quite possible once control is stable, but as a planned step with your practice, not by quietly leaving it out.
Not necessarily. In COPD, according to the guideline, a long-acting beta-2 agonist on its own is a standard treatment if the symptoms are mild to moderate and exacerbations are not frequent. In COPD, cortisone is only added in specific cases. But do ask whether you have been checked for asthmatic features — if so, the asthma rule applies.
The interaction check reviews all your medicines — including those from other practices.
A reminder for every inhaler, your reliever puffs over time and an interaction check in one place. Free.
Create medication plan